Buchumschlag

Assessment of Off‐Label Psychotropic Drug Use in Children and Adolescents: A Multi‐Center Cross‐Sectional Study in China

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Yue‐Peng Teng, Cai‐Dong Li, Wen‐Juan Lei, Jun Wu, Ya‐Ya Wang, Min Meng, Liu‐Cheng Li, Cui‐Li Yue
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2026
Schlagworte:	Pharmacoepidemiology and Drug Safety
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Disparity in Guideline‐Based Antidiabetic Drugs Prescribing for Type 2 Diabetes Patients in Primary Healthcare Facilities Across China, 2017–2019
von: Mengyuan Fu, et al.
Veröffentlicht: (2024)

Pharmacotherapeutic Monitoring and Drug‐Related Problems in a Group of Patients From Colombia: Cross‐Sectional Study, 2023–2024
von: Luis Fernando Valladales‐Restrepo, et al.
Veröffentlicht: (2026)

The Effects of Removing the Requirement for Prior Reimbursement Approval on Anticoagulant Use in Ireland: A Cross‐Sectional Study
von: M. Scannell, et al.
Veröffentlicht: (2024)

Curriculum in Pharmacoepidemiology Training Programs: A Cross‐Sectional Study to Assess Educational Needs and Alignment With Core Competencies
von: Amie Goodin, et al.
Veröffentlicht: (2026)

The European Drug–Drug Interaction (EuroDDI) Study Protocol: A Cross‐Country Comparison of Drug–Drug Interaction Prevalence in the Older Community‐Dwelling Population
von: John E. Hughes, et al.
Veröffentlicht: (2025)

Comparison of Prescribing Information for Elderly Patients on Drug Labels in Japan, the United States, and Europe
von: Makoto Onohara, et al.
Veröffentlicht: (2025)

Antidepressant Use Trajectories and Risk of Discontinuation After Adolescents and Young Adult Cancer Diagnosis
von: Oluwadamilola Onasanya, et al.
Veröffentlicht: (2025)

Mental Health and Medicine Use for Headache: A Nationally Representative Study of Adolescents in Denmark
von: Bjørn Evald Holstein, et al.
Veröffentlicht: (2024)

Time Windows Used When Identifying Current Drug Use and Polypharmacy
von: Sabrina Giometto, et al.
Veröffentlicht: (2026)

The Prevalent New‐User Design to Study Drug–Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe Hypoglycemia
von: Wanqi Wang, et al.
Veröffentlicht: (2024)

Risk of Ischaemic Stroke Varies With Antithrombotic Drugs Use in Proton Pump Inhibitor Users: A Self‐Controlled Case Series Study
von: Min Fan, et al.
Veröffentlicht: (2025)

Use of Omalizumab for Pediatric Asthma After US Food and Drug Administration Expanded Indications
von: Anjali D. Deshmukh, et al.
Veröffentlicht: (2024)

Incidence and Clinical Significance of Drug‐Induced Antibodies and Hemolytic Anemia Associated With Beta‐Lactam Antibiotics: A Prospective Cohort Study
von: Li Wang, et al.
Veröffentlicht: (2026)

Use of Potentially Nephrotoxic Drugs in Type 2 Diabetes Patients on SGLT2i: A Trajectories Analysis
von: Lanting Yang, et al.
Veröffentlicht: (2025)

Potential Drug Dose‐Specific Adverse Three‐Drug Combinations: A US Insurance Claims Data‐Based Study
von: Y. Shi, et al.
Veröffentlicht: (2025)

Methodological Characteristics in Economic Evaluations of Health Technology Assessment Reports Submitted for Drug Reimbursement in Brazilian Public Health
von: Gilson Pires Dorneles, et al.
Veröffentlicht: (2026)

A Methodological Review of Simulation Studies Published in Pharmacoepidemiology and Drug Safety
von: Ryan Muddiman, et al.
Veröffentlicht: (2026)

Measuring Exposure to Opioids Using Self‐Reported Medication Use Data Versus General Practitioner Prescription Records in the UK Biobank Study
von: Allison Domingues, et al.
Veröffentlicht: (2025)

Have People Treated With Antihypertensives Been Diagnosed With Hypertension? A Cross‐Sectional Study in Stockholm, Sweden
von: Indre Treciokiene, et al.
Veröffentlicht: (2025)

Association of Pharmacist Interventions With Adverse Drug Events and Potential Adverse Drug Events
von: W. N. Kelly, et al.
Veröffentlicht: (2024)

A Cross‐Sectional Survey of Evidence Needs for Medicinal Products in Europe With a Focus on Real‐World Evidence
von: Maria Melinder, et al.
Veröffentlicht: (2026)

PMDA Perspective on RWD/RWE Utilization for Regulatory Purposes Including Assessment on the Impacts of Regulatory Actions and Safety Risk of a Drug at Postmarketing Stage
von: Kazuhiro Kajiyama, et al.
Veröffentlicht: (2024)

Current Use of Common Data Models in the Nordic Countries
von: Gerard Ompad, et al.
Veröffentlicht: (2025)

Proton Pump Inhibitor Use Exceeding the U.S. Food and Drug Administration Approved Treatment Duration for Patients With Peptic Ulcer Disease: A Retrospective Cohort Study
von: Jordan A. Villars, et al.
Veröffentlicht: (2025)

Impact of COVID ‐19 Restrictions on Nationwide Antipsychotic Use: Results From the Trends in Drug Utilization During COVID ‐19 Pandemic in Turkey ( PANDUTI ‐ TR ) Study
von: Caner Vizdiklar, et al.
Veröffentlicht: (2026)

Agreement of Medication Information Derived From EHR Data Compared to Medicare Insurance Claims: An Analysis of Biologic Disease‐Modifying Antirheumatic Drugs
von: Jing Li, et al.
Veröffentlicht: (2024)

Real‐World Use of Biologic and Targeted Synthetic Disease‐Modifying Antirheumatic Drugs in Patients With Axial Spondyloarthritis in the United States: Persistence, Variables Associated With Persistence, and Dosing Variations
von: Maureen Dubreuil, et al.
Veröffentlicht: (2025)

Characteristics of United States Food and Drug Administration Drug Recalls Involving Opioid Medications, 2002–2025
von: Julio C. Nunes, et al.
Veröffentlicht: (2026)

Drug Safety: Being Vigilant… or Proactive?
von: Alain Braillon
Veröffentlicht: (2026)

Effectiveness of the Additional Risk Minimisation Measures for Valproate Among Healthcare Professionals and Patients: A Cross‐Sectional Survey in Six European Countries
von: Sandrine Colas, et al.
Veröffentlicht: (2024)

A Review of Concordance and Quality in Clinical Guidelines for Hormonal Contraceptives to Mitigate Drug–Drug Interactions in Women With Epilepsy
von: Matthew R. Muschett, et al.
Veröffentlicht: (2024)

Trajectories of Treatment Disruption for Chronic Outpatient Medications for U.S. Veterans During Drug Shortages
von: Katie J. Suda, et al.
Veröffentlicht: (2026)

Changes in the Use of Hydrochlorothiazide and Other Antihypertensive Drugs in Switzerland in Association With the Swissmedic Safety Alert Regarding Non‐melanoma Skin Cancer: An Interrupted Time‐Series Analysis Using Swiss Claims Data
von: Tamino Zappalà, et al.
Veröffentlicht: (2024)

Prescriber Adherence to Antihypertensive Prescription Guidelines and the Impact of Patient Socioeconomic Factors: A Cross‐Sectional Study Using Data From the Irish Longitudinal Study on Ageing
von: Alizeh Akhtar, et al.
Veröffentlicht: (2024)

Comparing the Centers for Medicare and Medicaid Services (CMS) enrollment data death dates to the National Death Index (NDI)
von: Dinci Pennap, et al.
Veröffentlicht: (2024)

National Trends and Disparities in Herpes Zoster Vaccination Among US Older Adults With Diabetes, 2008–2023
von: Chun‐Tse Hung, et al.
Veröffentlicht: (2025)

Use of Valproic Acid Among Women of Childbearing Age and Its Concomitant Use With Contraceptives in Colombia
von: Jorge E. Machado‐Alba, et al.
Veröffentlicht: (2025)

Keep Your Guard Up: The Potential Impact of Drug Shortages on Pharmacoepidemiological Studies
von: Araniy Santhireswaran, et al.
Veröffentlicht: (2024)

Ondansetron Use for Women With Hyperemesis Gravidarum and Risks of Spontaneous Abortion and Stillbirth: A Retrospective Cohort Study
von: Jianzhou Yang, et al.
Veröffentlicht: (2026)

The Impact of Balance Solution on the Outcomes of Incident Peritoneal Dialysis Patients
von: I‐Kuan Wang, et al.
Veröffentlicht: (2026)